Dr. Khalid Matin
Claim this profileVirginia Commonwealth University/Massey Cancer Center
Studies Colorectal Cancer
Studies Colon Cancer
14 reported clinical trials
30 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
dMMR positive
2Colon Cancer
Stage IV
Stage III
dMMR positive
Affiliated Hospitals
Clinical Trials Khalid Matin is currently running
Chemotherapy + Radiation
for Rectal Cancer
This is phase 2 trial of neoadjuvant therapy and short-course radiotherapy in resectable rectal cancer.
Recruiting1 award Phase 215 criteria
Fruquintinib
for Colorectal Cancer
High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American and/or Hispanic/Latino with refractory metastatic colorectal cancer (mCRC) have a bigger risk of higher blood pressure after treatment with fruquintinib. The main aim of this study is to learn how often adults of a minority group experience hypertension after they have been treated with fruquintinib for refractory mCRC. Other aims are to learn how safe fruquintinib is and how well it is tolerated by participants. Participants will receive fruquintinib in 4-week treatment cycles until their condition worsens, they do no longer tolerate the treatment or stop the treatment for other reasons. After the last treatment, participants will be checked upon every 3 months until study completion.
Recruiting3 awards Phase 46 criteria
More about Khalid Matin
Clinical Trial Related6 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Khalid Matin has experience with
- Fluorouracil
- Oxaliplatin
- Irinotecan
- Bevacizumab
- Leucovorin Calcium
- Atezolizumab
Breakdown of trials Khalid Matin has run
Colorectal Cancer
Colon Cancer
Rectal Cancer
DNA Repair Deficiency
Lynch Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Khalid Matin specialize in?
Khalid Matin focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Khalid Matin currently recruiting for clinical trials?
Yes, Khalid Matin is currently recruiting for 5 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Khalid Matin has studied deeply?
Yes, Khalid Matin has studied treatments such as Fluorouracil, Oxaliplatin, Irinotecan.
What is the best way to schedule an appointment with Khalid Matin?
Apply for one of the trials that Khalid Matin is conducting.
What is the office address of Khalid Matin?
The office of Khalid Matin is located at: Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University/Massey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.